IDWEEK Live Interview |Dr. Hardy：Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales
AmpC β-lactamases are class C serine β-lactamases that can be produced by a number of Enterobacteriaceae and glucose non-fermenting Gram-negative bacteria. Although AmpC β-lactamases have been associated with the development of third-generation cephalosporin resistance, this risk of AmpC deinhibition is not the same in different enterobacteria. At the recent Infectious Diseases Week 2023 (IDWeek 2023) conference, Professor Megan E. Hardy, a clinical pharmacologist in infectious diseases from the West Virginia University School of Medicine (WVU Medicine) in the United States, orally reported the results of a study titled, "Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales" and shared his fascinating insights in an interview with Infectious Disease Frontier.
